Supplementary Figure 1 from Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status

Autor:	Annette K. Larsen, Aimery de Gramont, Thierry André, Christophe Tournigand, Benoist Chibaudel, Ariel Savina, Alexandre E. Escargueil, Michèle Sabbah, Nathalie Ferrand, Anaïs Bouygues, Paul Mésange
Rok vydání:	2023
Popis:	Influence of bevacizumab (Beva), erlotinib (Erlo) and their combination (Beva + Erlo) on the tumor growth of CRC xenografts.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112e1e45b02ce7b61fd6dc9c56691276 https://doi.org/10.1158/1078-0432.22470387.v1 Zobrazit plný text záznamu